Cargando…
Positron emission tomography in the management of lung cancer
(18) F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a useful technique to characterize the solitary pulmonary nodule, diagnose primary lung cancer, carry out mediastinal and extrathoracic staging, plan radiotherapy, therapeutic response assessment and detect recurrence. PET may help...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732081/ https://www.ncbi.nlm.nih.gov/pubmed/19727351 http://dx.doi.org/10.4103/1817-1737.32235 |
| _version_ | 1782171005863591936 |
|---|---|
| author | Kakhki, Vahid Reza Dabbagh |
| author_facet | Kakhki, Vahid Reza Dabbagh |
| author_sort | Kakhki, Vahid Reza Dabbagh |
| collection | PubMed |
| description | (18) F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a useful technique to characterize the solitary pulmonary nodule, diagnose primary lung cancer, carry out mediastinal and extrathoracic staging, plan radiotherapy, therapeutic response assessment and detect recurrence. PET may help to determine the ideal site for tissue diagnosis as well as predict prognosis. Combined PET and computed tomography (PET / CT) has the best of both worlds of metabolic and anatomic imaging and may provide optimal disease assessment. |
| format | Text |
| id | pubmed-2732081 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | Medknow Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27320812009-09-02 Positron emission tomography in the management of lung cancer Kakhki, Vahid Reza Dabbagh Ann Thorac Med Review Article (18) F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a useful technique to characterize the solitary pulmonary nodule, diagnose primary lung cancer, carry out mediastinal and extrathoracic staging, plan radiotherapy, therapeutic response assessment and detect recurrence. PET may help to determine the ideal site for tissue diagnosis as well as predict prognosis. Combined PET and computed tomography (PET / CT) has the best of both worlds of metabolic and anatomic imaging and may provide optimal disease assessment. Medknow Publications 2007 /pmc/articles/PMC2732081/ /pubmed/19727351 http://dx.doi.org/10.4103/1817-1737.32235 Text en © Annals of Thoracic Medicine http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Review Article Kakhki, Vahid Reza Dabbagh Positron emission tomography in the management of lung cancer |
| title | Positron emission tomography in the management of lung cancer |
| title_full | Positron emission tomography in the management of lung cancer |
| title_fullStr | Positron emission tomography in the management of lung cancer |
| title_full_unstemmed | Positron emission tomography in the management of lung cancer |
| title_short | Positron emission tomography in the management of lung cancer |
| title_sort | positron emission tomography in the management of lung cancer |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732081/ https://www.ncbi.nlm.nih.gov/pubmed/19727351 http://dx.doi.org/10.4103/1817-1737.32235 |
| work_keys_str_mv | AT kakhkivahidrezadabbagh positronemissiontomographyinthemanagementoflungcancer |